April 9, 2013
/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
Global Molecular Diagnostics Market & Future Forecast to 2017 Overview
The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is expected to double its market size in 2017 from the market of 2012.
Molecular Diagnostics Market - Application Segment Analysis
• The infectious disease testing is the leading application in Molecular Diagnostic. It is likely to hold XXXX% share in 2017.• Molecular oncology tests have emerged as a second significant rapidly growing market segment. Genetic Testing and Blood Screening are at the third and fourth spot respectively in 2012.• The cardiovascular disease testing and neurological testing are closely competing with each other to gain the maximum market share.• Food testing market is expected to inch up to US$ XXXX Million in 2017.
Molecular Diagnostics Market - Technologies Segment Analysis
• Biochips and PCR based test accounts for the largest shares in the molecular diagnostics technologies segment with XXXX% and XXXX% respectively in 2012.• Fish & Innovations technology market is at the 3rd slot.• The PCR related technologies and Non- PCR market is at the 4th and 5th position respectively. • The biosensor and Molecular Imaging technology are also showing impressive growth.